Stocklytics Platform
Asset logo for symbol BSX
Boston Scientific
BSX74
$74.92arrow_drop_up0.88%$0.66
High Quality
S&P500
Asset logo for symbol BSX
BSX74

$74.92

arrow_drop_up0.88%

Performance History

Chart placeholder
Key Stats
Open$74.50
Prev. Close$74.26
EPS1.23
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
LOWHIGH
Day Range74.42
75.67
52 Week Range48.35
79.43
Ratios
EPS1.23

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Correlated Companies

Price$804.62
Perf. (24h)
arrow_drop_down2.01%-$16.57
Market Cap$738.87B
Price$569.71
Perf. (24h)
arrow_drop_up1.79%$10.03
Market Cap$527.83B
Price$160.64
Perf. (24h)
arrow_drop_up0.62%$1.00
Market Cap$382.01B
Price$185.16
Perf. (24h)
arrow_drop_up1.64%$2.99
Market Cap$326.96B

About Boston Scientific (BSX)

Boston Scientific Corp (BSX) is a leading global medical technology company that develops and manufactures innovative devices used in a wide range of medical procedures. The company's mission is to improve patient outcomes and quality of life by providing physicians with advanced tools and technologies. With a market cap of over $50 billion, Boston Scientific is a major player in the healthcare industry. The company's stock price history has shown steady growth over the years, reflecting its strong performance and market demand for its products.
One key factor investors consider when evaluating a stock is its price-to-earnings growth (PEG) ratio. Boston Scientific Corp has a PEG ratio of 1.85, indicating that the stock is reasonably priced relative to its expected earnings growth. This ratio is calculated by dividing the stock's P/E ratio by its projected earnings growth rate. A PEG ratio below 1.0 is generally considered favorable, as it suggests the stock may be undervalued. In comparison to its industry peers, Boston Scientific Corp has a competitive PEG ratio, demonstrating its potential for future growth.
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Michael F. Mahoney
Headquarters
Marlborough
Employees
45000
Exchange
NYSE
add Boston Scientific to watchlist

Keep an eye on Boston Scientific

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Boston Scientific's (BSX) price per share?
The current price per share for Boston Scientific (BSX) is $74.92. The stock has seen a price change of $0.66 recently, indicating a 0.89% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Boston Scientific (BSX)?
For Boston Scientific (BSX), the 52-week high is $79.43, which is 6.02% from the current price. The 52-week low is $48.35, the current price is 54.95% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Boston Scientific (BSX) a growth stock?
Boston Scientific (BSX) has shown an average price growth of 0.41% over the past three years. It has received a score of 81 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Boston Scientific as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Boston Scientific (BSX) stock price performance year to date (YTD)?
As of the latest data, Boston Scientific (BSX) has a year-to-date price change of 29.53%. Over the past month, the stock has experienced a price change of -2.83%. Over the last three months, the change has been 2.39%. Over the past six months, the figure is 22.56%. Looking at a longer horizon, the five-year price change stands at 78.04%.
help
Is Boston Scientific (BSX) a profitable company?
Boston Scientific (BSX) has a net income of $1.59B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 69.49% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 20.39% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $14.24B, with a revenue growth rate of 12.29%, providing insight into the company's sales performance and growth. The gross profit is $9.9B. Operating income is noted at $2.34B. Furthermore, the EBITDA is $3.79B.
help
What is the market capitalization of Boston Scientific (BSX)?
Boston Scientific (BSX) has a market capitalization of $110.15B. The average daily trading volume is 8.11M, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level